Momentum

Relative Strength (%)
1m+34.96%
3m
6m
1yr
Volume Change (%)
10d/3m
Price vs... (%)
52w High-12.26%
50d MA
200d MA

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Financial Summary

Year End 30th JunUnit201720182019202020212022E2023ECAGR / Avg
Total Revenue£m302.3381.2456.9466.7523.6556.54611.099.03%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+17.4+14.21+15.78+13.65-29.64+69.65+13.6n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Latest News & Insights for CLIN

Here is what expert analysts think about Clinigen background image

Here is what expert analysts think about Clinigen

City analysts understand the companies they cover better than anyone - so it can pay to take note of their trading recommendations. 'Buy', 'hold' and 'sell' ratings can be a useful signal when it comes to deciding whether to buy a shar...

The Clinigen share price – where next? background image

The Clinigen share price – where next?

The Clinigen (LON:CLIN) share price has risen by 5.63% over the past month and it’s currently trading at 637.5p. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will continue...

What do analysts think about Clinigen? background image

What do analysts think about Clinigen?

Company analysts usually understand the stocks they cover better than just about anyone else. For that reason, it can be useful to know whether they think investors should 'buy', 'hold' or 'sell' them. These kinds of clues can give you...

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Jun 202230th Jun 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Clinigen EPS forecast chart

Profile Summary

Clinigen Group plc is a United Kingdom-based pharmaceutical and services company. The Company's principal activities include management, sale and distribution of pharmaceutical products, which have associated expiry dates. The Company operates through five segments: Clinigen Clinical Trial Services (CTS), which sources commercial medical products for use in clinical studies, including comparator drugs, adjuvant drugs and rescue therapies; Idis Managed Access (MA), which is engaged in the consultancy, development, management and implementation of managed access programs for biotechnology and pharmaceutical companies; Idis Global Access (GA), which offers ethical access to post approval and short-supply medicines; Clinigen Specialty Pharmaceuticals (SP), which manufactures and distributes its own and in-licensed specialist, hospital-only medicines around the world, and Link Healthcare, which distributes pharmaceutical products in South Africa, and the Asia and Pacific region.

Directors

Last Annual
June 30th, 2021
Last Interim
June 30th, 2021
Incorporated
December 12th, 2008
Public Since
September 25th, 2012
No. of Employees
1,013
Sector
Biotechnology & Medical Research
Industry
Healthcare
Exchange
gb flag iconLondon Stock Exchange
Shares in Issue
133,366,726

CLIN Share Price Performance

Latest News for CLIN

Upcoming Events for CLIN

Half Year 2022 Clinigen Group PLC Earnings Release

Similar to CLIN

Picture of 4Basebio logo

4Basebio

gb flag iconLondon Stock Exchange

Picture of 4d Pharma logo

4d Pharma

gb flag iconLondon Stock Exchange

Picture of Allergy Therapeutics logo

Allergy Therapeutics

gb flag iconLondon Stock Exchange

Arecor Therapeutics

gb flag iconLondon Stock Exchange

Picture of Avacta logo

Avacta

gb flag iconLondon Stock Exchange

FAQ

Or unlock with your email

Or unlock with your email